表紙
市場調查報告書

糖尿病:近年開發動向、產品創新、治療

Latest Development, Product Innovations and Treatments for Diabetes

出版商 BCC Research 商品編碼 926327
出版日期 內容資訊 英文 237 Pages
訂單完成後即時交付
價格
糖尿病:近年開發動向、產品創新、治療 Latest Development, Product Innovations and Treatments for Diabetes
出版日期: 2020年02月14日內容資訊: 英文 237 Pages
簡介

全球糖尿病治療市場預計從2019年到2024年會成長5.0%的複合年均增長率(CAGR),預測市場規模會從2019年的809億美元擴大至2024年的1,032億美元。北美糖尿病治療市場預計會從2019年的345億擴大至2024年的426億美元,預測從2019年到2024年期間的CAGR為4.3%。亞太糖尿病治療市場預計會從2019年的212億擴大至2024年的198億美元,預測從2019年到2024年期間的CAGR為7.1%。

本報告研究糖尿病治療,提供糖尿病疾病驗證、糖尿病流行病學驗證、地區別資料與統計、全球及地區別的未來糖尿病發生率、罹患率預測、糖尿病對現在及未來的影響的預測、在各產品部門現在可使用的產品驗證、高糖尿病藥相關研究、血糖監測、診斷系統及裝置的最新技術進步分析,以及主要企業檔案等。

第1章 簡介

  • 簡介
  • 糖尿病
  • 1型糖尿病
  • 2型糖尿病
  • 研究範圍
  • 研究方法、資訊來源
  • 一手資料與資訊收集
  • 二手資料與資訊收集
  • 市場獲益預測
  • 分析家經歷
  • BCC的客製研究
  • BCC Research的相關報告

第2章 摘要和重點提要

  • 糖尿病治療全球市場
  • 地區概要
  • 市場部門區分
  • 創新的糖尿病治療技術的主要開發與動向
  • 血糖監測及診斷系統與裝置
  • 胰島素輸遞裝置
  • 糖尿病藥

第3章 糖尿病的簡介與對全球健康的威脅

  • 糖尿病簡介
  • 何謂糖尿病?
  • 糖尿病種類
  • 1型糖尿病
  • 2型糖尿病
  • 妊娠糖尿病(GDM)或妊娠中的高血糖
  • 耐糖障礙(IGT)及空腹時耐糖障礙(IFG)
  • 糖尿病流行病學
  • 性別分佈
  • 地區落差
  • 地區別資料與統計
  • 主要統計、最新資料:北美及加勒比海地區
  • 主要統計、最新資料:歐洲
  • 主要統計、最新資料:南部及中部美洲
  • 主要統計、最新資料:東南亞
  • 主要統計、最新資料:西太平洋
  • 主要統計、最新資料:中東及北非
  • 主要統計、最新資料:非洲
  • 20∼79歲的糖尿病患者數排名前10的國家/地區
  • 未被診斷的糖尿病
  • 糖尿病相關醫療費

第4章 血糖監測及診斷系統與裝置

  • 血糖監測及診斷系統與裝置的概要
  • 血糖的自我監測(SMBG)
  • SMBG的市場結構
  • 血糖裝置的最新技術性進步與開發
  • 連續葡萄糖監測(CGM)系統
  • CGM系統的歷史與開發

第5章 胰島素輸遞裝置

  • 胰島素輸遞裝置的簡介
  • 胰島素注射器
  • 使用胰島素注射器的優點
  • 使用胰島素注射器的缺點
  • 胰島素注射器的最新技術性進步與開發
  • 胰島素輸遞筆型裝置
  • 拋棄式胰島素筆
  • 可重複使用的胰島素筆
  • 胰島素輸遞筆型裝置的最新技術性進步與開發
  • 胰島素噴射注射器
  • 使用胰島素噴射注射器的優點
  • 使用胰島素噴射注射器的缺點
  • 體外胰島素幫浦
  • 胰島素幫浦的優點
  • 胰島素幫浦的缺點
  • 胰島素幫浦系統的最新技術性進步與開發
  • 皮下型胰島素幫浦
  • 閉環人工胰臟
  • 仿生胰臟/人工胰臟
  • 人工胰臟(生理學途徑)
  • 吸入型胰島素
  • 吸入型胰島素的優點
  • 吸入型胰島素的缺點
  • 吸入型胰島素的種類
  • 胰島素貼片
  • PROMETHEUS PHARMA
  • CeQur SA
  • EOFlow
  • Zenomics Inc.
  • 經口輸遞胰島素
  • Novo Nordisk 與 NIH 為 MIT 的研究提供資金
  • Oramed Pharmaceuticals
  • Diabetology Ltd.

第6章 抗糖尿病藥

  • 簡介
  • 抗糖尿病藥的分類與種類
  • 糖尿病的注射療法
  • 經口抗糖尿病藥(OAD)
  • 面臨專利懸崖
  • 糖尿病治療藥的最新技術進步、開發及產品研發
  • 現在的產品研發
  • 現在研究中的其他潛在治療藥

第7章 糖尿病治療的地區市場

  • 簡介
  • 糖尿病治療全球市場
  • 地區概要
  • 北美糖尿病治療市場
  • 歐洲糖尿病治療市場
  • 亞太糖尿病治療市場
  • 拉丁美洲糖尿病治療市場
  • 中東及非洲糖尿病治療市場
  • 促進糖尿病醫藥品市場成長與發展的市場因素
  • 市場成長促進要素
  • 市場成長阻礙要素

第8章 葡萄糖監測、診斷產品的全球市場

  • 簡介
  • 全球葡萄糖監測、診斷產品市場
  • 地區市場概要
  • 地區別葡萄糖監測、診斷產品市場
  • 北美洲
  • 歐洲
  • 亞洲及太平洋
  • 拉丁美洲
  • 中東及非洲
  • 全球市佔率分析
  • 葡萄糖監測、診斷產品
  • 血糖檢查試紙、葡萄糖檢測計、刺胳針及刺胳針裝置
  • 連續葡萄糖監測產品

第9章 胰島素輸遞產品、裝置全球市場

  • 簡介
  • 全球胰島素輸遞產品、裝置市場
  • 地區市場概要
  • 地區別胰島素輸遞產品、裝置市場
  • 北美洲
  • 歐洲
  • 亞洲及太平洋
  • 拉丁美洲
  • 中東及非洲
  • 市佔率分析

第10章 糖尿病治療藥全球市場

  • 簡介
  • 全球糖尿病治療藥市場
  • 地區市場概要
  • 地區別糖尿病治療藥市場
  • 北美洲
  • 歐洲
  • 亞洲及太平洋
  • 拉丁美洲
  • 中東及非洲
  • 市佔率分析

第11章 公司檔案

  • 簡介
  • Tier 1
  • ABBOTT LABORATORIES
  • ASCENSIA DIABETES CARE HOLDINGS AG
  • ASTRAZENECA PLC
  • BAYER AG
  • BECTON, DICKINSON AND CO.
  • BECKMAN COULTER (PART OF DANAHER)
  • BOSTON SCIENTIFIC CORP.
  • B. BRAUN MELSUNGEN AG
  • ELI LILLY AND CO.
  • GLAXOSMITHKLINE PLC
  • INSULET CORP.
  • JOHNSON & JOHNSON
  • LIFESCAN INC.
  • MEDTRONIC INC.
  • NOVO NORDISK A/S
  • PFIZER INC.
  • ROCHE (FORMERLY HOFFMANN-LA ROCHE LTD.)
  • SANOFI S.A.
  • Terumo
  • Tier 2
  • AGAMATRIX INC.
  • ALTUCELL INC.
  • BETA-O2 TECHNOLOGIES
  • BETALIN THERAPEUTICS
  • DARIOHEALTH CORP.
  • DEXCOM INC.
  • EVOTEC SE
  • LEXICON PHARMACEUTICALS INC.
  • MESOBLAST LTD.
  • NEXTCELL PHARMA AB
  • ORGENESIS INC.
  • OSIRIS THERAPEUTICS INC. (SUBSIDIARY OF SMITH & NEPHEW PLC)
  • SENSEONICS HOLDINGS INC.
  • SERNOVA CORP.
  • SERAXIS INC.
  • TANDEM DIABETES CARE, INC.
  • VALERITAS HOLDINGS INC.
  • VIACYTE INC.
  • VTV THERAPEUTICS INC.
  • UNICYTE AG
  • YPSOMED HOLDING AG

第12章 附錄:A

章13:附錄:B

章14:附錄:C

章15:附錄:D

目錄
Product Code: HLC249A

Report Highlights:

The global diabetes treatment market should grow from $80.9 billion in 2019 to $103.2 billion by 2024 at a compound annual growth rates (CAGR) of 5.0% for the period of 2019-2024.

North American diabetes treatment market should grow from $34.5 billion in 2019 to $42.6 billion by 2024 at a CAGR of 4.3% for the period of 2019-2024.

Asia-Pacific diabetes treatment market should grow from $21.2 billion in 2019 to $29.8 billion by 2024 at a CAGR of 7.1% for the period of 2019-2024.

Report Scope:

The key objectives of this study are to -

Review the impact that diabetes is having on global health. This includes -

  • Review of diabetes as a disease.
  • Review of the epidemiology of diabetes.
  • Data and statistics by region.
  • Predictions of future incidence and prevalence of diabetes globally and by region.
  • Review of the impact that diabetes has and will have in the future.
  • Review of the current products available within the following individual product segment and subsegments.
  • Blood glucose monitoring and diagnostic systems and devices.
  • Insulin-delivery devices.
  • Antidiabetic medications.

Review the latest technological advances and developments in blood glucose monitoring and diagnostic systems and devices. This includes -

  • Flash glucose monitoring (FGM).
  • New and novel approaches to blood glucose monitoring.
  • Review of the latest developments in continuous glucose monitoring (CGM) systems.

Review the latest technological advances and developments in insulin-delivery devices. This includes -

  • Insulin syringes.
  • Insulin pens and needles (reusable and disposable).
  • Insulin jet injectors.
  • External insulin pumps.
  • Implantable insulin pumps.
  • Insulin inhalers.
  • Insulin patches.

Review the latest technological advances and pipeline developments in Antidiabetic medications. This includes -

  • Review of the classification of Antidiabetic medications under the titles of injectable Antidiabetic medications and oral Antidiabetic drugs (OADS).
  • Review of the current product pipeline for new and innovative Antidiabetic medications.
  • Review the range of joint ventures, collaborations, licenses and research agreements currently focused on new medical device technologies.
  • Review of the regulatory requirements, intellectual property protection and concerns, patents and trademark process.
  • Review of the impact that the new and improved technologies will have on market dynamics by geographic region.
  • Survey of the key players involved in the development of new and innovative medical device technologies and Antidiabetic medications together with major improvements to existing technologies, as well as company profiles.

By purchasing this study, the reader will gain -

  • An improved understanding of the current state, future developments and latest product innovations in both medical devices and medications used to treat diabetes.
  • The latest information on the leading companies engaged in developing new and improving existing medical devices and medications, a review of the status of their product pipelines and insight into their proprietary technologies.
  • An understanding of the impact that these new products and technologies will have on the growth and development of the medical market.
  • An appreciation of how these new medical devices and medications will affect the provision of healthcare, how they will provide clinicians with new methods to treat existing conditions and how these technologies will improve clinical outcomes for patients.
  • An appreciation of the market restraints and drivers influencing the growth and development of this market.
  • The impact that diabetes has on the population and the implications as a global pandemic.

The analysis includes the use of charts and graphs measuring product growth and trends within the marketplace. Company-specific information, including sales figures, product pipeline status and R&D trends, is provided throughout the report.

Report Includes:

  • 72 data tables and 33 additional tables
  • An overview of global market for diabetes treatment and discussion on latest developments and product innovations in the industry
  • Analyses of global market trends, with data from 2018, 2019, and projections of compound annual growth rates (CAGRs) through 2024
  • Coverage of diabetes background, its prevalence and its threat to world health
  • Briefing about blood glucose monitoring and diagnostic systems and devices
  • Discussion on top drug treatments and their latest breakthroughs
  • Information on the artificial, or "Bionic" pancreas
  • A look at the measures taken to confront diabetes at the local, regional, national and trans-national level by raising awareness in parliaments and assemblies across the world
  • Evaluation of current market size, market forecast, and market share analysis of the leading suppliers of the industry
  • Insights into individual country policies and strategies to combat diabetes
  • Comprehensive company profiles of key players in the market, including Abbott Laboratories, Becton, Dickinson and Co., Eli Lilly and Co., GlaxoSmithKline PLC and NextCell Pharma AB

Table of Contents

Chapter 1: Introduction

  • Introduction
  • Diabetes
    • Type 1 Diabetes
    • Type 2 Diabetes
  • Scope of Report
  • Methodology and Information Sources
    • Primary Data and Information Gathering <
    li>Secondary Data and Information Gathering
  • Market Revenue Forecasts
  • Analyst's Credentials
  • BCC Custom Research
  • Related BCC Research Reports

Chapter 2: Summary and Highlights

  • Global Market for Diabetes Treatments
  • Regional Overview
  • Market Segmentation
  • Major Developments and Trends in Innovative Diabetes Treatment Technologies
    • Blood Glucose Monitoring and Diagnostic Systems and Devices
    • Insulin Delivery Devices
    • Diabetic Medications

Chapter 3: Introduction to Diabetes and Its Threat to World Health

  • Introduction to Diabetes
  • What is Diabetes?
  • Types of Diabetes
    • Type 1 Diabetes
    • Type 2 Diabetes
    • Gestational Diabetes Mellitus (GDM) or Hyperglycemia in Pregnancy
    • Impaired Glucose Tolerance (IGT) and Impaired Fasting Glucose (IFG)
  • Epidemiology of Diabetes
    • Gender Distribution
    • Regional Disparities
  • Data and Statistics by Region
    • Key Facts and Latest Data: North America and the Caribbean Region
    • Key Facts and Latest Data: Europe
    • Key Facts and Latest Data: South and Central America
    • Key Facts and Latest Data: Southeast Asia
    • Key Facts and Latest Data: Western Pacific
    • Key Facts and Latest Data: Middle East and North Africa
    • Key Facts and Latest Data: Africa
    • Top 10 Countries/Territories for Number of People Aged 20-79 with Diabetes
    • Undiagnosed Diabetes
    • Healthcare Expenditure Associated with Diabetes

Chapter 4: Blood Glucose Monitoring and Diagnostic Systems and Devices

  • Introduction to Blood Glucose Monitoring and Diagnostic Systems and Devices
  • Self-Monitoring of Blood Glucose (SMBG)
    • SMBG Market Structure
    • Latest Technological Advances and Developments in Blood Glucose Devices
  • Continuous Glucose Monitoring (CGM) Systems
    • History and Development of CGM Systems

Chapter 5: Insulin Delivery Devices

  • Introduction to Insulin Delivery Devices
  • Insulin Syringes
    • Advantages of Using Insulin Syringes
    • Disadvantages of Using Insulin Syringes
    • Latest Technological Advances and Developments in Insulin Syringes
  • Insulin Delivery Pen Devices
    • Disposable Insulin Pens
    • Reusable Insulin Pens
    • Latest Technological Advances and Developments in Insulin Delivery Pen Devices
  • Insulin Jet Injectors
    • Advantages of Using Insulin Jet injectors
    • Disadvantages of Using Insulin Jet injectors
  • External Insulin Pumps
    • Advantages of Insulin Pumps
    • Disadvantages of Insulin Pumps
    • Latest Technological Advances and Developments in Insulin Pump Systems
  • Implantable Insulin Pumps
    • Closed-Loop Artificial Pancreas
    • Bionic Pancreas
    • The Artificial Pancreas (the Physiological Approach)
  • Insulin Inhalers
    • Advantages of Insulin Inhalers
    • Disadvantages of Insulin Inhalers
    • Types of Insulin Inhalers
  • Insulin Patches
    • Prometheon Pharma
    • CeQur SA
    • EOFlow
    • Zenomics Inc.
  • Oral Insulin Delivery
    • Novo Nordisk and NIH Funds Research at MIT
    • Oramed Pharmaceuticals
    • Diabetology Ltd.

Chapter 6: Antidiabetic Medications

  • Introduction
  • Classification and Types of Antidiabetic Medications
    • Injectable Therapies for Diabetes
    • Oral Antidiabetic Drugs (OADs)
  • Facing the Patent Cliff
  • Latest Technological Advances, Developments and Product Pipelines for Diabetic Medications
    • Current Product Pipeline
    • Other Potential Therapies Currently Under Investigation

Chapter 7: Regional Markets for Diabetes Treatments

  • Introduction
  • Global Market for Diabetes Treatments
  • Regional Overview
    • North American Market for Diabetes Treatments
    • European Market for Diabetes Treatments
    • Asia-Pacific Market for Diabetes Treatments
    • Latin American Market for Diabetes Treatments
    • Middle Eastern and African Market for Diabetes Treatments
  • Market Factors Driving the Growth and Development of the Diabetic Pharmaceutical Market
    • Market Drivers
    • Market Restraints

Chapter 8: Global Market for Glucose Monitoring and Diagnostic Products

  • Introduction
  • Global Glucose Monitoring and Diagnostic Product Market
    • Overview of the Regional Markets
  • Glucose Monitoring and Diagnostic Product Market by Region
    • North America
    • Europe
    • Asia-Pacific
    • Latin America
    • Middle East and Africa
  • Global Market Share Analysis
    • Glucose Monitoring and Diagnostic Products
    • Blood Glucose Test Strips, Glucose Meters, Lancets and Lancet Devices
    • Continuous Glucose Monitoring Products

Chapter 9: Global Market for Insulin Delivery Products and Devices

  • Introduction
  • Global Insulin Delivery Products and Devices Market
    • Overview of the Regional Markets
  • Insulin Delivery Products and Device Market by Region
    • North America
    • Europe
    • Asia-Pacific
    • Latin America
    • Middle East and Africa
  • Market Share Analysis

Chapter 10: Global Market for Antidiabetic Pharmaceuticals

  • Introduction
  • Global Antidiabetic Pharmaceutical Market
    • Overview of the Regional Markets
  • Antidiabetic Pharmaceuticals Market by Region
    • North America
    • Europe
    • Asia-Pacific
    • Latin America
    • Middle East and Africa
  • Market Share Analysis

Chapter 11: Company Profiles

  • Introduction
  • Tier 1 Major Multinational Medical Device Corporations
    • ABBOTT LABORATORIES
    • ASCENSIA DIABETES CARE HOLDINGS AG
    • ASTRAZENECA PLC
    • BAYER AG
    • BECTON, DICKINSON AND CO.
    • BECKMAN COULTER (PART OF DANAHER)
    • BOSTON SCIENTIFIC CORP.
    • B. BRAUN MELSUNGEN AG
    • ELI LILLY AND CO.
    • GLAXOSMITHKLINE PLC
    • INSULET CORP.
    • JOHNSON & JOHNSON
    • LIFESCAN INC.
    • MEDTRONIC INC.
    • NOVO NORDISK A/S
    • PFIZER INC.
    • ROCHE (FORMERLY HOFFMANN-LA ROCHE LTD.)
    • SANOFI S.A.
    • TERUMO CORP.
    • Tier 2 Entrepreneurial Small and Medium-Sized Enterprises
    • AGAMATRIX INC.
    • ALTUCELL INC.
    • BETA-O2 TECHNOLOGIES
    • BETALIN THERAPEUTICS
    • DARIOHEALTH CORP.
    • DEXCOM INC.
    • EVOTEC SE
    • LEXICON PHARMACEUTICALS INC.
    • MESOBLAST LTD.
    • NEXTCELL PHARMA AB
    • ORGENESIS INC.
    • OSIRIS THERAPEUTICS INC. (SUBSIDIARY OF SMITH & NEPHEW PLC)
    • SENSEONICS HOLDINGS INC.
    • SERNOVA CORP.
    • SERAXIS INC.
    • TANDEM DIABETES CARE, INC.
    • VALERITAS HOLDINGS INC.
    • VIACYTE INC.
    • VTV THERAPEUTICS INC.
    • UNICYTE AG
    • YPSOMED HOLDING AG

Chapter 12: Appendix: A

  • Company Contact Information
    • Tier 1 Major Multinational Medical Device Corporations

Chapter 13: Appendix: B

  • Company Contact Information
    • Tier 2 Entrepreneurial Small and Medium-Sized Enterprises (SMEs)

Chapter 14: Appendix: C

  • Government Regulatory Agencies and Professional Organizations

Chapter 15: Appendix: D

  • Acronyms and Terms Commonly Used in the Diagnosis, Monitoring and Treatment of Diabetes

List of Tables

  • Summary Table A: Global Market for Diabetes Treatment, Through 2024
  • Summary Table B: Global Market for Diabetes Treatment, by Region, Through 2024
  • Summary Table C: Global Market Shares of Diabetes Treatment, by Region, 2019
  • Summary Table D: Global Market for Diabetes Treatment, by Product Segment/Subsegment, Through 2024
    • Table 1: Key Facts and Latest Data for Diabetes Globally, 2017 and 2045
    • Table 2: IDF Regions Ranked by Prevalence of Diabetes Population Aged 20-79 Years per Region, 2017 and 2045
    • Table 3: Key Facts and Latest Data for Diabetes Across the North American and Caribbean Regions, 2017 and 2045
    • Table 4: Key Facts and Latest Data for Diabetes in Europe, 2017 and 2045
    • Table 5: Key Facts and Latest Data for Diabetes in South and Central America, 2017 and 2045
    • Table 6: Key Facts and Latest Data for Diabetes in Southeast Asia, 2017 and 2045
    • Table 7: Key Facts and Latest Data for Diabetes in Western Pacific, 2017 and 2045
    • Table 8: Key Facts and Latest Data for Diabetes in the Middle East and North Africa, 2017 and 2045
    • Table 9: Key Facts and Latest Data for Diabetes in Africa, 2017 and 2045
    • Table 10: Top 10 Countries/Territories with People Aged 20-79 Years Living with Diabetes, 2017 and 2045
    • Table 11: People Aged 20-79 Years Living with Undiagnosed Diabetes by Region, 2017
    • Table 12: Top 10 Countries with People Aged 20-79 Years Living with Undiagnosed Diabetes, 2017
    • Table 13: Ranking of Top 10 Countries Based on Total Healthcare Expenditures on People Aged 20-79 Years with Diabetes, 2017
    • Table 14: Leading Blood Glucose Manufacturers and Blood Glucose Products
    • Table 15: Leading Lancet and Lancet Device Manufacturers and Products
    • Table 16: Comparison of Abbott Freestyle Blood Glucose Monitoring System Readers
    • Table 17: Leading Insulin Syringes Manufacturers and Insulin Syringe Products
    • Table 18: Commercially Available Insulin Injector Pens
    • Table 19: Leading Insulin Jet Injectors Manufacturers and Products
    • Table 20: Leading External Insulin Pump Manufacturers and Products
    • Table 21: Key Features of Current Leading Insulin Pump Systems
    • Table 22: Comparison of Insulin Action of Leading Insulin Products
    • Table 23: Comparison of GLP-1 Analogs
    • Table 24: U.S. Patent Expiry Dates for the World's Top Selling Diabetes Drugs
    • Table 25: Novo Nordisk's Current R&D Pipeline
    • Table 26: Eli Lilly and Co.'s Current R&D Pipeline
    • Table 27: AstraZeneca's Current R&D Pipeline
    • Table 28: Terminology Used to Describe Generic Biopharmaceuticals, by Country/Region
    • Table 29: Global Market for Diabetes Treatment Technologies, Through 2024
    • Table 30: Global Market for Diabetes Treatment, by Product Segment/Subsegment, Through 2024
    • Table 31: Global Market Shares of Diabetes Treatment Technologies, by Product Segment/Subsegment, 2019
    • Table 32: Global Market Shares of Diabetes Treatment Technologies, by Region, 2019
    • Table 33: Global Market for Diabetes Treatment, by Region, Through 2024
    • Table 34: North American Market for Diabetes Treatment, by Product Segment, Through 2024
    • Table 35: European Market for Diabetes Treatment, by Product Segment, Through 2024
    • Table 36: Asia-Pacific Market for Diabetes Treatment, by Product Segment, Through 2024
    • Table 37: Latin American Market for Diabetes Treatment, by Product Segment, Through 2024
    • Table 38: Middle Eastern and African Market for Diabetes Treatment, by Product Segment, Through 2024
    • Table 39: Global Market for Glucose Monitoring and Diagnostic Products, Through 2024
    • Table 40: Global Market for Glucose Monitoring and Diagnostic Products, by Product Subsegment, Through 2024
    • Table 41: Global Market Shares of Glucose Monitoring and Diagnostic Products, by Product Subsegment, 2019
    • Table 42: Global Market Shares of Glucose Monitoring and Diagnostic Products, by Region, 2019
    • Table 43: Global Market for Glucose Monitoring and Diagnostic Products, by Region, Through 2024
    • Table 44: North American Market for Glucose Monitoring and Diagnostic Products, by Country, Through 2024
    • Table 45: European Market for Glucose Monitoring and Diagnostics Products, by Country, Through 2024
    • Table 46: Asia-Pacific Market for Glucose Monitoring and Diagnostic Products, by Country, Through 2024
    • Table 47: Latin American Market for Glucose Monitoring and Diagnostic Products, by Country, Through 2024
    • Table 48: Middle Eastern and African Market for Glucose Monitoring and Diagnostic Products, by Country/Region, Through 2024
    • Table 49: Global Company Market Shares of Glucose Monitoring and Diagnostic Products, 2019
    • Table 50: Global Market Shares of Blood Glucose Test Strips, Glucose Meters, Lancets and Lancet Devices, by Company, 2019
    • Table 51: Global Company Market Shares of Continuous Glucose Monitoring Products, 2019
    • Table 52: Global Market for Insulin Delivery Products and Devices, Through 2024
    • Table 53: Global Market for Insulin Delivery Products and Devices, by Type, Through 2024
    • Table 54: Global Market Shares of Insulin Delivery Products and Devices, by Type, 2019
    • Table 55: Global Market Shares of Insulin Delivery Products and Devices, by Region, 2019
    • Table 56: Global Market for Insulin Delivery Products and Devices, by Region, Through 2024
    • Table 57: North American Market for Insulin Delivery Products and Devices, by Country, Through 2024
    • Table 58: European Market for Insulin Delivery Products and Devices, by Country, Through 2024
    • Table 59: Asia-Pacific Market for Insulin Delivery Products and Devices, by Country, Through 2024
    • Table 60: Latin American Market for Insulin Delivery Products and Devices, by Country, Through 2024
    • Table 61: Middle Eastern and African Market for Insulin Delivery Products and Devices, by Country/Region, Through 2024
    • Table 62: Global Company Market Shares of Insulin Delivery Products and Devices, 2019
    • Table 63: Global Market for Diabetic Pharmaceuticals, Through 2024
    • Table 64: Global Market for Diabetic Pharmaceuticals, by Product Type, Through 2024
    • Table 65: Global Market Shares of Diabetic Pharmaceuticals, by Product Type, 2019
    • Table 66: Global Revenues of Leading Antidiabetic Pharmaceutical Companies, 2016-2018
    • Table 67: Global Market Shares of Diabetic Pharmaceuticals, by Region, 2019
    • Table 68: Global Market for Diabetic Pharmaceuticals, by Region, Through 2024
    • Table 69: North American Market for Antidiabetic Pharmaceuticals, by Country, Through 2024
    • Table 70: European Market for Antidiabetic Pharmaceuticals, by Country, Through 2024
    • Table 71: Major Chinese Pharmaceutical Companies Developing Antidiabetic Medicines, by Type
    • Table 72: Asia-Pacific Market for Antidiabetic Pharmaceuticals, by Country, Through 2024
    • Table 73: Latin American Market for Antidiabetic Pharmaceuticals, by Country, Through 2024
    • Table 74: Middle Eastern and African Market for Antidiabetic Pharmaceuticals, by Country/Region, Through 2024
    • Table 75: Global Market Shares of Antidiabetic Pharmaceutical Companies, 2019
    • Table 76: Abbott Laboratories Revenue, by Business Segment, 2016-2018
    • Table 77: AstraZeneca PLC Revenue, by Business Segment, 2016-2018
    • Table 78: AstraZeneca PLC Revenue, by Individual Product, 2018
    • Table 79: Becton Dickinson Revenue, by Business Segment, 2016-2018
    • Table 80: Danaher Corp. Revenue, by Business Segment, 2016-2018
    • Table 81: Boston Scientific Corp. Revenue, by Product Segment, 2016-2018
    • Table 82: Boston Scientific Corp. Recent Developments, August 2018-May 2019
    • Table 83: B. Braun Melsungen AG Revenue, by Product Segment, 2016-2018
    • Table 84: Eli Lilly and Co. Revenue, by Product Segment, 2016-2018
    • Table 85: GlaxoSmithKline PLC Revenue, by Product Segment, 2016-2018
    • Table 86: Insulet Corp. Revenue, by Product Segment, 2016-2018
    • Table 87: Johnson & Johnson Revenue, by Product Segment, 2016-2018
    • Table 88: Medtronic Inc. Revenue, by Product Segment, 2017-2019
    • Table 89: Medtronic Inc. Recent Developments, June 2014-May 2019
    • Table 90: Novo Nordisk A/S Revenue, by Product Segment, 2016-2018
    • Table 91: Novo Nordisk A/S Revenue, Diabetes and Obesity, 2016-2018
    • Table 92: Novo Nordisk A/S Revenue, Biopharmaceuticals, 2016-2018
    • Table 93: Novo Nordisk A/S: Product Development Portfolio
    • Table 94: Pfizer Inc. Revenue, by Product Segment, 2016-2018
    • Table 95: Roche Group Revenue, by Product Segment, 2016-2018
    • Table 96: Roche Group Revenue, by Diagnostic Segment, 2016-2018
    • Table 97: Roche Group: Product Development Portfolio (Diagnostics)
    • Table 98: Sanofi S.A. Revenue, by Product Segment, 2016-2018
    • Table 99: Sanofi S.A. Diabetes Revenue, by Product Segment, 2016-2018
    • Table 100: Terumo Corp. Revenue, by Business Division, 2016-March 31, 2018
    • Table 101: Contact Information for Tier 1 Major Multinational Medical Device Corporations
    • Table 102: Contact Information for Tier 2 Entrepreneurial Small and Medium-Sized Enterprises
    • Table 103: Government Regulatory Agencies and Professional Organizations
    • Table 104: Acronyms and Terms Commonly Used in the Diagnosis, Monitoring and Treatment of Diabetes

List of Figures

  • Summary Figure A: Global Market Sharehlcs of Diabetes Treatment, by Region, 2019
  • Summary Figure B: Global Market Shares of Diabetes Treatment, by Product Segment/Subsegment, 2019
    • Figure 1: Global Number of People Aged 20-79 Years Living with Diabetes, by Region, 2017 and 2045
    • Figure 2: Expenditure Gap in Diabetes: Total Amount Spent and Amount per Person Spent Across IDF Regions
    • Figure 3: The Hidden Diabetes Epidemic: Proportion of Early Deaths, Undiagnosed Diabetes and Number of People Living with Diabetes per Region
    • Figure 4: Administration Route for Insulin Delivery
    • Figure 5: Schematic of a Closed-loop Artificial Pancreas System
    • Figure 6: Schematic of the Edmonton Protocol
    • Figure 7: Product Pipeline Portfolio of Diabetology Ltd.
    • Figure 8: Classification of Injectable Therapies for Diabetes
    • Figure 9: Classification of Oral Antidiabetic Drugs (OADs)
    • Figure 10: Global Initiatives Pertaining to Type 2 Diabetes
    • Figure 11: Type 2 Diabetes Agents in Clinical Development
    • Figure 12: Clinical Development Pipeline for Hanmi Pharma Co. Ltd.
    • Figure 13: Global Market Shares of Diabetes Treatment Technologies, by Product Segment/Subsegment, 2019
    • Figure 14: Global Market Shares of Diabetes Treatment Technologies, by Product Segment/Subsegment, 2019
    • Figure 15: Global Market Shares of Diabetes Treatment Technologies, by Region, 2019
    • Figure 16: North American Market for Diabetes Treatment, by Product Segment, 2018-2024
    • Figure 17: European Market for Diabetes Treatment, by Product Segment, 2018-2024
    • Figure 18: Asia-Pacific Market for Diabetes Treatment, by Product Segment, 2018-2024
    • Figure 19: Latin American Market for Diabetes Treatment, by Product Segment, 2018-2024
    • Figure 20: Middle Eastern and African Market for Diabetes Treatments, by Product Segment, 2018-2024
    • Figure 21: Global Market Shares of Glucose Monitoring and Diagnostic Products, by Product Subsegment, 2019
    • Figure 22: Global Market Shares of Glucose Monitoring and Diagnostic Products, by Region, 2019
    • Figure 23: North American Market Shares of Glucose Monitoring and Diagnostic Products, by Country, 2019
    • Figure 24: European Market Shares of Glucose Monitoring and Diagnostic Products, by Country, 2019
    • Figure 25: Key Components of the German Statutory Health Insurance System, 2017
    • Figure 26: Evolution of Statutory Health Insurance Suppliers in Europe, 1970-2018
    • Figure 27: Asia-Pacific Market Shares of Glucose Monitoring and Diagnostic Products, by Country, 2019
    • Figure 28: Latin American Market Shares of Glucose Monitoring and Diagnostics Products, by Country, 2019
    • Figure 29: Middle Eastern and African Market Shares of Glucose Monitoring and Diagnostic Products, by Country/Region, 2019
    • Figure 30: Global Company Market Shares of Glucose Monitoring and Diagnostic Products, 2019
    • Figure 31: Global Company Market Shares of Blood Glucose Test Strips, Glucose Meters, Lancets and Lancet Devices, by Company,2019
    • Figure 32: Global Company Market Shares of Continuous Glucose Monitoring Products, 2019
    • Figure 33: Global Market Shares of Insulin Delivery Products and Devices, by Type, 2019
    • Figure 34: Global Market Shares of Insulin Delivery Products and Devices, by Region, 2019
    • Figure 35: North American Market Shares of Insulin Delivery Products and Devices, by Country, 2019
    • Figure 36: European Market Shares of Insulin Delivery Products and Devices, by Country, 2019
    • Figure 37: Asia-Pacific Market Shares of Insulin Delivery Products and Devices, by Country, 2019
    • Figure 38: Latin American Market Shares of Insulin Delivery Products and Devices, by Country, 2019
    • Figure 39: Middle East and African Market Shares of Insulin Delivery Products and Devices, by Country/Region, 2019
    • Figure 40: Global Company Market Shares of Insulin Delivery Products and Devices, 2019
    • Figure 41: Global Market Shares of Diabetic Pharmaceuticals, by Product Type, 2019
    • Figure 42: Evolution of the Top Selling Diabetes Drugs Globally, 2010-2018
    • Figure 43: Global Market Shares of Diabetic Pharmaceuticals, by Region, 2019
    • Figure 44: North American Market for Antidiabetic Pharmaceuticals, by Country, 2019
    • Figure 45: European Market Shares of Antidiabetic Pharmaceuticals, by Country, 2019
    • Figure 46: Asia-Pacific Market Shares of Antidiabetic Pharmaceuticals, by Country, 2019
    • Figure 47: Latin American Market Shares of Antidiabetic Pharmaceuticals, by Country, 2019
    • Figure 48: Middle Eastern and African Market Shares of Antidiabetic Pharmaceuticals, by Country/Region, 2019
    • Figure 49: Global Market Shares of Antidiabetic Pharmaceutical Companies, 2019